RUMORED BUZZ ON CERIVASTATIN SODIUM

In studies exactly where cerivastatin sodium continues to be administered concomitantly with cholestyramine, no adverse reactions unique to this mixture or As well as those Earlier noted for this course of medicine were described. Myopathy and rhabdomyolysis (with or with no acute renal failure) are noted when HMG-CoA reductase inhibitors are used